相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transduction of Nonhuman Primate Brain with Adeno-Associated Virus Serotype 1: Vector Trafficking and Immune Response
Piotr Hadaczek et al.
HUMAN GENE THERAPY (2009)
Real-time MR imaging of adeno-associated viral vector delivery to the primate brain
Massimo S. Fiandaca et al.
NEUROIMAGE (2009)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
Efficient gene therapy-based method for the delivery of therapeutics to primate cortex
Adrian P. Kells et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Controlled dissemination of AAV vectors in the primate brain
Vanja Varenika et al.
NEUROTHERAPY: PROGRESS IN RESTORATIVE NEUROSCIENCE AND NEUROLOGY (2009)
Current status of gene therapy trials for Parkinson's disease
Massimo Fiandaca et al.
EXPERIMENTAL NEUROLOGY (2008)
Safety of real-time convection-enhanced delivery of liposomes to primate brain: A long-term retrospective
Michal T. Krauze et al.
EXPERIMENTAL NEUROLOGY (2008)
Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery
Vanja Varenika et al.
JOURNAL OF NEUROSURGERY (2008)
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
William J. Marks et al.
LANCET NEUROLOGY (2008)
Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain
Janet Cunningham et al.
MOLECULAR THERAPY (2008)
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
J. L. Eberling et al.
NEUROLOGY (2008)
Image-guided convection-enhanced delivery platform in the treatment of neurological diseases
Massimo S. Fiandaca et al.
NEUROTHERAPEUTICS (2008)
A single injection of an Adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease
Cassia N. Cearley et al.
JOURNAL OF NEUROSCIENCE (2007)
Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles
Nicholas J. Szerlip et al.
JOURNAL OF NEUROSURGERY (2007)
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions
Russell R. Lonser et al.
JOURNAL OF NEUROSURGERY (2007)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse
Marco A. Passini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
Krystof S. Bankiewicz et al.
MOLECULAR THERAPY (2006)
The perivascular pump driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain
P Hadaczek et al.
MOLECULAR THERAPY (2006)
Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys
MM Daadi et al.
NEUROREPORT (2006)
Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease
JC Dodge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging
MT Krauze et al.
BRAIN RESEARCH PROTOCOLS (2005)
AAV8-Mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease
CM Barbon et al.
MOLECULAR THERAPY (2005)
AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease
MA Passini et al.
MOLECULAR THERAPY (2005)
Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease
EY Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Effect of hyperosmolar mannitol on convection-enhanced delivery into the rat brain stem
DI Sandberg et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Gene therapy of Canavan disease:: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain
C Janson et al.
HUMAN GENE THERAPY (2002)
Critical issues in gene therapy for neurologic disease
G Hsich et al.
HUMAN GENE THERAPY (2002)
Gene therapy for lysosomal storage disorders
EM Novelli et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function
S Marathe et al.
HUMAN MOLECULAR GENETICS (2000)
Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer
A Bosch et al.
HUMAN GENE THERAPY (2000)
分享论文
